LIV-1/SLC39A6 Antibody (MMAE)

• Catalog Number: orb1805475
• Category: Antibodies
• Description: Anti-LIV-1 / SLC39A6 Reference Antibodyand Monomethyl auristatin E (MMAE) used for the study of breast cancer.
• Target: LIV-1 / SLC39A6
• Clonality: Recombinant
• Conjugation: MMAE
• Reactivity: Human
• Concentration: Batch dependent
• Buffer/Preservatives: 100 mM Proline/Acetic acid 20mM Arginine pH 5.0
• Purity: >95%
• Purification: Protein A
• UniProt ID: Q13433
• MW: 146.96 kDa
• Tested applications: ELISA, FA, FACS, In vivo
• Antibody Type: Recombinant Antibody
• Expression System: CHO
• Endotoxins: <0.001 EU/ug
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin)is more than 98.2% ;determined by SEC-HPLC.

Immobilized human LIV 1; His Tag at 2 μg/mL can bind Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin);EC50=0.007652μg/mL.

Human LIV1 CHOS cells were stained with Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab vedotin) and negative control protein respectively; washed and then followed by PE and analyzed with FACS; EC220=0.07456 ug/mL.